Quality of glycemic control according to hemoglobin versus fasting glycemia: Analysis in an urban and a rural population of Costa Rican diabetics

Authors

  • Adriana Laclé Murray Universidad de Costa Rica
  • Manuel Francisco Jiménez Navarrete Caja Costarricense del Seguro Social, Hospital de La Anexión

DOI:

https://doi.org/10.51481/amc.v46i3.148

Keywords:

Diabetes mellitus, hemoglobina glicosilada, control glicémico, glicemia en ayunas

Abstract

Introduction:Glycosilated hemoglobin(HbA1c) is at pre-sent the best available test to reflect the metaboliccontrol ofdiabetic patients, however its useis not yet systematic in ournational health system.

Objective:To determinethequality of metabolic con-trolofCosta Rican diabetics by urbanization level, accordingto fasting blood glucose orHbA1c and tocompare their res-pective equivalent values.

Study design and methods:Retrospective study comparingthe twoparameters mentioned above, 237 diabetics contro-lled at 6 Primary Health Carecenters(EBAIS) of an ur-banHealth Area (Desamparados, one county of the San Joséprovince), and257 diabetics controlled in 3 Primary HealthCare Centers (EBAIS) of a rural Health Area, (Nicoya, onecounty of the province of Guanacaste), during the year2000.In the patients of Desamparados the blood glucose clo-sest to the month of July of2000 and its respective HbA1c,taken the same day, was registered.In those diabetics fromNicoya the averageblood glucose and HbA1cof the year2000 was used for the study.

Results:Fasting blood glucose in the urban diabeticswasmore frequently at higher levels: 35% >200 mg/dl, 20.5%between 141-180 mg/dl and only17.9% were within normalranges (60-110 mg/dl), thus exhibiting poor metabolic con-trol.Diabetics from the rural area had similar results,with27% over200mg/dl, 22.9% in the ranges of 141-180 and22.3% within normal ranges.

The HbA1c resultswere not adequate either, at the urban set-ting, 34.6% were overthe critical values of 9.5%, and only21.1% were lower than 6.5%, compared to 40.4% and 14.0%,respectively in the rural area.

When the equivalent ranges of fasting blood glucose werecompared with HbA1c, big differences were found; for nor-mal glycemic ranges (60-110mg/dl), only 58.5% of the urbandata, and 65.3% of the rurals, coincided with its equivalent ofHbA1c (< 6.5%); 30% of the urban patients and 37% ruralpatients had for this same values, HbA1c over 8%. When thevalues of blood glucose were over 200 mg/dl, the relationwith its HbA1c equivalent range (> 9.5%) was high:75.6%in urban area and 82.9 % in the rural area.

Conclusion:glycosilated hemoglobin is the best method toevaluate the quality of metabolic controlin diabetic patients,especially inthose that handle fasting levels <200 mg/dl. InCosta Rica glycosilated hemoglobin determination has notbeen generalized at primary health level and too many pa-tients are not receiving the benefit of an intensive therapy, be-cause they are being evaluated only with fasting blood gluco-se. The implementation of glycosilated hemoglobin is posi-ble for our national health system and it should be compul-sory in all Health Areas of Costa Rica.

Downloads

Download data is not yet available.

References

Conget I. Diagnóstico, clasificación y patogenia de la diabetes melli-tus. Rev Esp Cardiol 2002 ; 55: 528-35.

American Public Health Association. Diabetes. En United BookPress Ed. Chronic Disease Epidemiology and Control Washington DC,USA, 1998: Chapter 14: 421.

Anónimo. El Proyecto de Reforma del Sector Salud. Acta Med Cos-tarric 1993; 36: 17-23.

Organización Panamericana de la Salud. Estadísticas vitales de saludde Costa Rica. www.paho.org/Spanish/SHA/prflcor.htm.

The UK Prospective Diabetes Study (UKPDS) Group. Intensiveblood-glucose control with sulphonylureas or insulin compared withconventional treatment and risk of complication in patients with type 2diabetes (UKPDS 33). Lancet 1998; 352: 837-853.

The Diabetes Control and Complications Trial Research Group.Theeffect of intensive treatment of diabetes on the development and pro-gression of long-term complications in insulin-dependent diabetes me-llitus. N Eng J Med 1993; 329: 977-986.

Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyoshi S, Ko-jima Y, Furuyoshi N y Shichiri M. Intensive insulin therapy preventsthe progression of diabetic microvascular complications in Japanesepatients with non-insulin dependent diabetes mellitus: a randomizedprospective 6 year study. Diabetes Res Clin Pract 1995; 28: 103-117.

Klein R. Hyperglycemia and microvascular and macrovascular disea-se. Diabetes Care 1995; 18: 258-268.

The Diabetes Control and Complications Trial Research Group. Therelationship of glycemic exposure (HbA1c) to the risk of developmentand progression of retinopathy in the Diabetes Control and Complica-tions Trial. Diabetes 1995; 44: 968-983.

Mathew C. Riddle, MD y Dianne M. Karl, HbA1c: La mejor forma demedir la calidad del tratamiento. Clinical Diabetes 1996; :79-82.

Jiménez MF y Ruíz L. Niveles de glicemia y de hemoglobina glicosi-lada en un grupo de diabéticos nicoyanos. Acta Med Costarric 2001;43 (suplemento 1): 15.

Laclé A. Perfil del paciente diabético tipo 2 de 55 y más años, de unaclínica periférica de la Caja Costarricense de Seguro Social. Acta MedCostarric 1999; 41:46-51.

Balma A. Diabetes Mellitus tipo II en la Clínica de Esparza. Medici-na, Vida y Salud 2002; 5:18.

Uiversidad de Costa Rica. Información general de Costa Rica.http://www.sibdi.bldt.ucr.ac.cr

Asociación Latinoamericana de Diabetes (ALAD). Guías ALAD 2002.www.alad.org/docs.html,

Caja Costarricense de Seguro Social. Departamento de Medicina Pre-ventiva. Manual para la Atención Integral de la Diabetes Mellitus en elPrimer Nivel de Atención (con énfasis en la DM tipo 2). Unidad de Im-prenta CCSS. Costa Rica, 2002.

American Association of Clinical Endocrinologists and the AmericanCollege of Endocrinology.The American Association of Clinical En-docrinologists Medical Guidelines for the Management of DiabetesMellitus:The AACE System of Intensive Diabetes Self-Management-2002 Update. Endocrine Practice 2002; 8 (Suppl.1): 41-65.

Padilla G, Aráuz AG y Sánchez G. Guía para la enseñanza en diabetesmellitus: primer nivel de atención en salud. Imprenta INCIENSA. TresRíos, Cartago, Costa Rica, 2002. .

American Diabetes Association. Standards of Medical Care for Pa-tients with Diabetes Mellitus. Diabetes Care 2002; 25 (supplement 1):S37.

Peters AL, Davidson MB, Schriger DL, Hasselblad V.Aclinical ap-proach for the diagnosis of diabetes mellitus: an analysis using glycosy-lated hemoglobin levels. Meta-analysis Research Group on the Diagno-sis of Diabetes Using Glycated Hemoglobin Levels. JAMA1996; 276:1246-1252.

Mazze RS, Etzwiler DD, Strock E, Peterson K, McClave CR 2nd, Mes-zaros JF, et al Staged diabetes management. Toward an integrated mo-del of diabetes care. Diabetes Care 1994(Suppl 1); 17: 56-66.

Harris MI, Eastman RC, Cowie CC, Flegal KM, Eberhardt MS. Racialand ethnic differences in glycemic control of adults with type 2 diabe-tes. Diabetes Care 1999; 22: 403-408.

Clark CM, Fradkin JE, Hiss RG, Lorenz RA, Vinicor F,Warren-Boul-ton E. Promoting Early Diagnosis and Treatment of Type 2 Diabetes.The National Diabetes Education Program. JAMA2000; 284: 363-365.

Caja Costarricense de Seguro Social. Plan de Atención a la Salud delas Personas. Corporación Litográfica Internacional S.A. San José,Costa Rica, 2002. Páginas 95 a 100

Downloads

Published

2004-07-01

How to Cite

Quality of glycemic control according to hemoglobin versus fasting glycemia: Analysis in an urban and a rural population of Costa Rican diabetics. (2004). Acta Médica Costarricense , 46(3), 139-144. https://doi.org/10.51481/amc.v46i3.148